查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405913

免疫测量市场规模、份额和趋势分析报告：按产品、按技术、按应用、按检体、按最终用途、按地区和细分市场预测，2024-2030 年

Immunoassay Market Size, Share & Trends Analysis Report By Product (Reagent & Kits, Analyzers/Instruments), By Technology (RIA, ELISA), By Application, By Specimen, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

免疫测量市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球免疫测量市场规模预计将达到 344.7 亿美元。

预计2024年至2030年该市场将以3.60%的复合年增长率扩张。 PoC 快速测试和自动免疫测量分析仪的推出正在推动市场成长。此外，慢性病和感染疾病的增加导致市场快速成长。

据美国癌症协会称，2020 年估计有 1690 万癌症患者/倖存者。根据美国美国癌症研究所2019年的资料，美国约有180万名癌症患者被诊断出来。根据美国癌症协会的数据，2019 年美国约有 606,880 人死于癌症。因此，癌症病例数量的增加正在推动对免疫测量的需求。预计这将推动未来几年的市场成长。

此外，人们对感染疾病和预防措施的认识不断提高，导致对快速诊断测试产品的需求旺盛，从而推动了销售成长。根据世界卫生组织《2018 年世界疟疾报告》的调查，製造商报告 2017 年侧向流动试验法的销售额为 2.76 亿份。另据报导，2017 年撒哈拉以南非洲约 75.0% 的疟疾病例是透过侧向流动试验法诊断的。

一些基于智慧型手机的设备和相关工具正在成为下一代护理点诊断和测试设备，推动市场成长。例如，智慧型手机应用程式与自主毛细管微流控晶片相结合，已用于快速检测心肌梗塞中的心肌肌钙蛋白 I。该平台在资源有限的环境下易于使用，可在12分钟内提供测试结果。因此，预计新的技术进步将在预测期内进一步推动市场。

西门子医疗有限公司于 2018 年 4 月宣布在美国首次实施采用 Aptio 自动化的 Atellica免疫测量解决方案。该产品的目的是为了在美国普及先进的技术产品。 2020 年12 月，丹纳赫旗下贝克曼库尔特(Beckman Coulter) 宣布推出首个用于COVID-19 抗原检测的高品质和高通量检测方法，正式命名为Access SARS-CoV-2 抗原检测方法。 2018 年 7 月，Cygnus Technologies 和 Gyros Protein Technologies 合作开发了免疫测量来识别生物治疗毒素。两家公司之间的策略联盟将主要致力于提供生物分析解决方案和提高生物治疗製造的效率。

免疫测量市场报告亮点

  • 酵素免疫测量（EIA）领域由于其在感染疾病和慢性病、食物过敏、药物滥用等检测中的重复使用，在2023年占据了最大的市场占有率，为63.39%。
  • 2023年，试剂和套件盒细分市场贡献最大份额，达66.16%。庞大的市场占有率归因于由于感染疾病和自体免疫疾病的盛行率上升，对免疫测量测定试剂和诊断套件的需求不断增加。
  • 从应用来看，传染病检查领域预计将在2023年占据最大的市场占有率，达到36.39%，并在预测期内以最快的复合年增长率成长。
  • 血液检体细分市场占比最大，2023年为43.11%。这是由于疾病发病率不断增加，推动了对各种血液检测程序的需求并支持了该领域的成长。
  • 按最终用途划分，医院细分市场占据主导地位，2023 年收益占有率为 32.94%。医院和诊所是诊断和治疗医疗状况的初级保健机构。
  • 北美地区2023年收益最高，收益占有率为40.60%。与慢性病相关的诊断需求的不断增长以及技术先进的诊断技术的可用性的增加预计将在预测期内推动市场成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 慢性病和感染疾病的发生率增加
    • 即时诊断的需求增加
    • 对便携式和自动化免疫测量的需求不断增长
  • 市场驱动因素
    • 检测下限值
    • 与免疫测量技术相关的局限性
  • 市场抑制因素分析
  • 营商环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
    • COVID-19感染疾病的影响分析

第四章 产品经营分析

  • 免疫测量市场：产品变异分析
  • 试剂和套件
    • 试剂和套件市场，2018-2030
    • ELISA 试剂和套件
    • 快速检测试剂和套件
    • ELISPOT 试剂与套件
    • 蛋白质印迹试剂和套件
    • 其他试剂和套件
  • 分析仪/设备
    • 分析仪/仪器市场，2018-2030
    • 开放式系统
    • 封闭式系统
  • 软体和服务
    • 软体与服务市场，2018-2030

第五章检体业务分析

  • 免疫测量市场：检体变异分析
  • 血
  • 唾液
  • 尿
  • 其他的

第六章技术商业分析

  • 免疫测量市场：技术变迁分析
  • 免疫测量
  • 酵素连结免疫测量快速检测
    • 化学冷光免疫测量法
    • 萤光免疫测量法
  • 其他的

第 7 章最终用途业务分析

  • 免疫测量市场：配销通路波动分析
  • 医院
  • 居家护理
  • 专科诊所
  • 其他的

第 8 章最终用途业务分析

  • 免疫测量市场：配销通路波动分析
  • 医院
  • 血库
  • 临床实验室
  • 製药和生物技术公司
  • 学术研究中心
  • 其他的

第九章区域业务分析

  • 2023 年及 2030 年按地区分類的免疫测量市场占有率
  • 北美洲
    • 北美免疫测量市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲免疫测量市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太免疫学分析市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲免疫测量市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • MEA 免疫分析市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争形势

  • 参与企业概况
  • 财务绩效
  • 参与企业
    • 市场领导者
    • 2023 年免疫测量分析市场占有率分析
    • 公司简介
    • 策略规划
Product Code: GVR-3-68038-066-8

Immunoassay Market Growth & Trends:

The global immunoassay market size is expected to reach USD 34.47 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.60% from 2024 to 2030. The introduction of PoC rapid tests and automated immunoassay analyzers is boosting market growth. In addition, the rising number of chronic and infectious diseases is leading to high market growth.

According to the American Cancer Society, there were an estimated 16.9 million cancer patients/survivors in 2020. Around 1.8 million cancer cases were diagnosed in the U.S., according to the National Cancer Institute 2019 data. According to the American Cancer Society, nearly 606,880 deaths occurred due to cancer in the U.S. in 2019. Thus, the rise in the number of cancer cases being diagnosed is driving the demand for immunoassays. This is expected to boost the market growth in the coming years.

Furthermore, growing awareness regarding infectious diseases and preventive measures has led to a high demand for rapid diagnostic test products, thereby increasing sales. Based on a survey by the WHO on the World malaria report 2018, manufacturers reported sales of 276 million for lateral flow assays in 2017. It also reported that around 75.0% of malaria cases were diagnosed using lateral flow assays in sub-Saharan Africa in 2017.

Several smartphone-based devices and associated tools have emerged as next-generation point-of-care diagnostics or testing devices, thereby boosting the market growth. For instance, a smartphone application combined with the autonomous capillary microfluidic chip is used for the rapid testing of cardiac troponin I in myocardial infarction. This platform can be easily used in resource-limited settings, providing test results within 12 minutes. Thus, novel technological advancements are anticipated to further drive the market over the forecast period.

The first implementation of the Atellica immunoassay solutions with Aptio automation in the United States was announced by Siemens Healthcare GmbH in April 2018. The objective of this product was designed to promote advanced technological products in the U.S. In December 2020, Beckman Coulter, a Danaher business, introduced its first high-quality as well as throughput assay for the COVID-19 antigen detection, officially named Access SARS-CoV-2 Antigen assay. In July 2018, Cygnus Technologies and Gyros Protein Technologies collaborated to produce immunoassay to identify biotherapeutic toxins. The two companies' strategic alliance will primarily focus on offering bioanalytical solutions and increasing biotherapeutics manufacturing efficiencies.

Immunoassay Market Report Highlights:

  • The enzyme immunoassays (EIA) segment held the largest market share of 63.39% in 2023, owing to their repeated usage in the detection of infectious and chronic diseases, food allergies, and drug abuse, among other applications.
  • The reagents and kits segment contributed to the largest share of 66.16% in 2023. A significant market share can be attributed to the increased demand for immunoassay reagents and diagnostic kits, owing to the rising prevalence of infectious and autoimmune diseases.
  • Based on application, the infectious diseases testing segment held the largest market share of 36.39% in 2023 and is anticipated to grow at the fastest CAGR over the forecast period.
  • The blood specimen segment held the largest share of 43.11% in 2023 attributed to an increase in disease occurrence, which drives demand for different blood testing procedures, supporting segment growth.
  • Based on end-use, the hospitals segment dominated the market in 2023 with a revenue share of 32.94%. Hospitals and clinics are primary care settings for the diagnosis and treatment of medical conditions.
  • North America generated the highest revenue in 2023 with a 40.60% revenue share. The rise in demand for diagnostics related to chronic diseases and the increase in availability of technologically advanced diagnostic techniques are expected to propel market growth over the forecast period.

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. Gvr's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Rising incidence of chronic and infectious diseases
    • 3.3.2. Increasing demand for point-of-care diagnostics
    • 3.3.3. Growing demand for portable and automated immunoassays
  • 3.4. Market Drivers
    • 3.4.1. Lower detection limit
    • 3.4.2. Limitations associated with immunoassay techniques
  • 3.5. Market Restraint Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Immunoassay market: Product Movement Analysis
  • 4.2. Reagents & Kits
    • 4.2.1. Reagents & Kits Market, 2018 - 2030 (USD Million)
    • 4.2.2. ELISA Reagents & Kits
      • 4.2.2.1. ELISA Reagents & Kits Market, 2018 - 2030 (USD Million)
    • 4.2.3. Rapid Test Reagents & Kits
      • 4.2.3.1. Rapid Test Reagents & Kits Market, 2018 - 2030 (USD Million)
    • 4.2.4. ELISPOT Reagents & Kits
      • 4.2.4.1. ELISPOT Reagents & Kits Market, 2018 - 2030 (USD Million)
    • 4.2.5. Western Blot Reagents & Kits
      • 4.2.5.1. Western Blot Reagents & Kits Market, 2018 - 2030 (USD Million)
    • 4.2.6. Other Reagents & Kits
      • 4.2.6.1. Other Reagents & Kits Market, 2018 - 2030 (USD Million)
  • 4.3. Analyzers/Instruments
    • 4.3.1. Analyzers/Instruments Market, 2018 - 2030 (USD Million)
    • 4.3.2. Open Ended Systems
      • 4.3.2.1. Open Ended Systems & Kits Market, 2018 - 2030 (USD Million)
    • 4.3.3. Close Ended Systems
      • 4.3.3.1. Close Ended Systems Reagents & Kits Market, 2018 - 2030 (USD Million)
  • 4.4. Software & Services
    • 4.4.1. Software & Services Market, 2018 - 2030 (USD Million)

Chapter 5. Specimen Business Analysis

  • 5.1. Immunoassay Market: Specimen Movement Analysis
  • 5.2. Blood
    • 5.2.1. Blood Market, 2018 - 2030 (USD Million)
  • 5.3. Saliva
    • 5.3.1. Saliva Market, 2018 - 2030 (USD Million)
  • 5.4. Urine
    • 5.4.1. Urine Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Technology Business Analysis

  • 6.1. Immunoassay Market: Technology Movement Analysis
  • 6.2. Radioimmunoassay
    • 6.2.1. Radioimmunoassay Market, 2018 - 2030 (USD Million)
  • 6.3. Enzyme Immunoassays Rapid Test
    • 6.3.1. Enzyme Immunoassays Rapid Test Market, 2018 - 2030 (USD Million)
    • 6.3.2. Chemiluminescence Immunoassays
      • 6.3.2.1. Chemilluminescence Immunoassays Market, 2018 - 2030 (USD Million)
    • 6.3.3. Fluroscence Immunoassays
      • 6.3.3.1. Fluroscence Immunoassays Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. End-use Business Analysis

  • 7.1. Immunoassay Market: Distribution Channel Movement Analysis
  • 7.2. Hospitals
    • 7.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 7.3. Homecare
    • 7.3.1. Homecare Market, 2018 - 2030 (USD Million)
  • 7.4. Specialty Clinics
    • 7.4.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. End-use Business Analysis

  • 8.1. Immunoassay Market: Distribution Channel Movement Analysis
  • 8.2. Hospitals
    • 8.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 8.3. Blood Banks
    • 8.3.1. Blood Banks Market, 2018 - 2030 (USD Million)
  • 8.4. Clinical Laboratories
    • 8.4.1. Clinical Laboratories Market, 2018 - 2030 (USD Million)
  • 8.5. Pharmaceutical and Biotech Companies
    • 8.5.1. Pharmaceutical and Biotech Companies Market, 2018 - 2030 (USD Million)
  • 8.6. Academic Research Centers
    • 8.6.1. Academic Research Centers Market, 2018 - 2030 (USD Million)
  • 8.7. Others
    • 8.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Immunoassay Market Share By Region, 2023 & 2030
  • 9.2. North America
    • 9.2.1. North America Immunoassay market, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Target Disease Prevalence
      • 9.2.2.3. Competitive Scenario
      • 9.2.2.4. Regulatory Framework
      • 9.2.2.5. Reimbursement Scenario
      • 9.2.2.6. U.S. Immunoassay market, 2018 - 2030 (USD MILLION)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Prevalence
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Regulatory Framework
      • 9.2.3.5. Reimbursement Scenario
      • 9.2.3.6. Canada Immunoassay market, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.2. Germany
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. Reimbursement Scenario
      • 9.3.2.6. Germany Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.3. UK
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. UK Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. France Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Prevalence
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Regulatory Framework
      • 9.3.5.5. Reimbursement Scenario
      • 9.3.5.6. Italy Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Prevalence
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Regulatory Framework
      • 9.3.6.5. Reimbursement Scenario
      • 9.3.6.6. Spain Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Prevalence
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Regulatory Framework
      • 9.3.7.5. Reimbursement Scenario
      • 9.3.7.6. Denmark Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Prevalence
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Regulatory Framework
      • 9.3.8.5. Reimbursement Scenario
      • 9.3.8.6. Sweden Immunoassay market, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Prevalence
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Regulatory Framework
      • 9.3.9.5. Reimbursement Scenario
      • 9.3.9.6. Norway Immunoassay market, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Immunoassay market, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. Reimbursement Scenario
      • 9.4.2.6. Japan Immunoassay market, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. China Immunoassay market, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. India Immunoassay market, 2018 - 2030 (USD Million)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. South Korea Immunoassay market, 2018 - 2030 (USD Million)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. Australia Immunoassay market, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Thailand Immunoassay market, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Immunoassay market, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Reimbursement Scenario
      • 9.5.2.6. Brazil Immunoassay market, 2018 - 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. Mexico Immunoassay market, 2018 - 2030 (USD Million)
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Reimbursement Scenario
      • 9.5.4.6. Argentina Immunoassay market, 2018 - 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA Immunoassay market, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Reimbursement Scenario
      • 9.6.2.6. South Africa Immunoassay market, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. Saudi Arabia Immunoassay market, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. Regulatory Framework
      • 9.6.4.5. Reimbursement Scenario
      • 9.6.4.6. UAE Immunoassay market, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Regulatory Framework
      • 9.6.5.5. Reimbursement Scenario
      • 9.6.5.6. Kuwait Immunoassay market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant's overview
  • 10.2. Financial performance
  • 10.3. Participant categorization
    • 10.3.1. Market Leaders
    • 10.3.2. Immunoassay market Share Analysis, 2023
    • 10.3.3. Company Profiles
      • 10.3.3.1. Siemens Healthineers
      • 10.3.3.1.1. Company Overview
      • 10.3.3.1.2. Financial Performance
      • 10.3.3.1.3. Product Benchmarking
      • 10.3.3.1.4. Strategic Initiatives
      • 10.3.3.2. bioMerieux SA
      • 10.3.3.2.1. Company Overview
      • 10.3.3.2.2. Financial Performance
      • 10.3.3.2.3. Product Benchmarking
      • 10.3.3.2.4. Strategic Initiatives
      • 10.3.3.3. Abbott Laboratories
      • 10.3.3.3.1. Company Overview
      • 10.3.3.3.2. Financial Performance
      • 10.3.3.3.3. Product Benchmarking
      • 10.3.3.3.4. Strategic Initiatives
      • 10.3.3.4. Danaher Corporation (Beckman Coulter)
      • 10.3.3.4.1. Company Overview
      • 10.3.3.4.2. Financial Performance
      • 10.3.3.4.3. Product Benchmarking
      • 10.3.3.4.4. Strategic Initiatives
      • 10.3.3.5. Quidel Corporation
      • 10.3.3.5.1. Company Overview
      • 10.3.3.5.2. Financial Performance
      • 10.3.3.5.3. Product Benchmarking
      • 10.3.3.5.4. Strategic Initiatives
      • 10.3.3.6. Ortho Clinical Diagnostics
      • 10.3.3.6.1. Company Overview
      • 10.3.3.6.2. Financial Performance
      • 10.3.3.6.3. Product Benchmarking
      • 10.3.3.6.4. Sysmex Corporation
      • 10.3.3.7. Bio-Rad Laboratories, Inc.
      • 10.3.3.7.1. Company Overview
      • 10.3.3.7.2. Financial Performance
      • 10.3.3.7.3. Product Benchmarking
      • 10.3.3.7.4. Strategic Initiatives
      • 10.3.3.8. Becton, Dickinson, and Company
      • 10.3.3.8.1. Company Overview
      • 10.3.3.8.2. Financial Performance
      • 10.3.3.8.3. Product Benchmarking
      • 10.3.3.8.4. Strategic Initiatives
      • 10.3.3.9. F. Hoffmann-La Roche AG
      • 10.3.3.9.1. Company Overview
      • 10.3.3.9.2. Financial Performance
      • 10.3.3.9.3. Product Benchmarking
      • 10.3.3.9.4. Strategic Initiatives
      • 10.3.3.10. Thermo Fisher Scientific, Inc
      • 10.3.3.10.1. Company Overview
      • 10.3.3.10.2. Financial Performance
      • 10.3.3.10.3. Product Benchmarking
      • 10.3.3.10.4. Strategic Initiatives
      • 10.3.3.11. Sysmex Corporation
      • 10.3.3.11.1. Company Overview
      • 10.3.3.11.2. Financial Performance
      • 10.3.3.11.3. Product Benchmarking
      • 10.3.3.11.4. Strategic Initiatives
    • 10.3.4. Strategy Mapping
      • 10.3.4.1. Expansion
      • 10.3.4.2. Acquisition
      • 10.3.4.3. Collaborations
      • 10.3.4.4. Disease Type/Drug Class Launch
      • 10.3.4.5. Partnerships
      • 10.3.4.6. Others

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 6 Global Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 7 Global Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 8 Global Immunoassays Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 North America Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 North America Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 North America Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 14 North America Immunoassays Market, by Country, 2018 - 2030 (USD Million)
  • Table 15 U.S. Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 U.S. Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 17 U.S. Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 18 U.S. Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 19 U.S. Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 20 Canada Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Canada Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 22 Canada Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Canada Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 24 Canada Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 25 Europe Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 Europe Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 Europe Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 Europe Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 29 Europe Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 30 Europe Immunoassays Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Germany Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Germany Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Germany Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 34 Germany Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 35 Germany Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 36 UK Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 37 UK Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 38 UK Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 39 UK Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 40 UK Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 41 France Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 France Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 France Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 France Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 45 France Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 46 Spain Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 Spain Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 48 Spain Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 49 Spain Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 50 Spain Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 51 Italy Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Italy Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 53 Italy Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 54 Italy Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 55 Italy Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 56 Denmark Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 Denmark Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 Denmark Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 59 Denmark Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 60 Denmark Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 61 Sweden Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 62 Sweden Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 63 Sweden Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 64 Sweden Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 65 Sweden Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 66 Norway Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Norway Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 68 Norway Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Norway Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 70 Norway Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Immunoassays Market, by Country, 2018 - 2030 (USD Million)
  • Table 77 South Korea Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 78 South Korea Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 79 South Korea Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 80 South Korea Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 81 South Korea Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 82 Thailand Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 83 Thailand Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 84 Thailand Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 Thailand Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 86 Thailand Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 87 Australia Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 88 Australia Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Australia Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 90 Australia Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 91 Australia Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 92 China Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 China Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 China Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 China Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 96 China Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 97 Japan Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 Japan Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 99 Japan Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 100 Japan Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 101 Japan Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 102 India Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 103 India Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 104 India Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 105 India Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 106 India Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 107 Latin America Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 108 Latin America Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 109 Latin America Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 110 Latin America Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 111 Latin America Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 112 Latin America Immunoassays Market, by Country, 2018 - 2030 (USD Million)
  • Table 113 Brazil Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Brazil Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 115 Brazil Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 116 Brazil Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 117 Brazil Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 118 Mexico Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 119 Mexico Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 120 Mexico Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 121 Mexico Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 122 Mexico Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 123 Argentina Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 124 Argentina Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 125 Argentina Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 126 Argentina Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 127 Argentina Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa Immunoassays Market, by Country, 2018 - 2030 (USD Million)
  • Table 134 South Africa Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 135 South Africa Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 136 South Africa Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 137 South Africa Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 138 South Africa Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 144 UAE Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 145 UAE Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 146 UAE Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 147 UAE Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 148 UAE Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Immunoassays Market, by Product, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Immunoassays Market, by Application, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Immunoassays Market, by Technology, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Immunoassays Market, by End-use, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Immunoassays Market, by Specimen, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Immunoassays Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2023
  • Fig. 15 Regional Marketplace: Key Takeaways
  • Fig. 16 Regional Outlook, 2023 & 2030
  • Fig. 17 North America Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 18 U.S. Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 19 Canada Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 20 Europe Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 21 Germany Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 22 UK Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 23 France Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 24 Spain Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 25 Italy Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 26 Russia Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 27 Asia Pacific Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 28 Japan Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 29 China Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 30 India Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 31 Australia Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 32 South Korea Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 33 Singapore Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 34 Latin America Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 35 Brazil Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 37 Argentina Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 38 Middle East and Africa Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 39 South Africa Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 40 Saudi Arabia Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 41 UAE Immunoassays Market, 2018 - 2030 (USD Million)
  • Fig. 42 Global Immunoassays Market, for, Reagents & Kits 2018 - 2030 (USD Million)
  • Fig. 43 Global Immunoassays Market, for, ELISA Reagents & Kits 2018 - 2030 (USD Million)
  • Fig. 44 Global Immunoassays Market, for, Rapid Test Reagents & Kits 2018 - 2030 (USD Million)
  • Fig. 45 Global Immunoassays Market, for, ELISPOT Reagents & Kits 2018 - 2030 (USD Million)
  • Fig. 46 Global Immunoassays Market, for, Western Blot Reagents & Kits 2018 - 2030 (USD Million)
  • Fig. 47 Global Immunoassays Market, for, Other Reagents & Kits 2018 - 2030 (USD Million)
  • Fig. 48 Global Immunoassays Market, for, Analyzers/Instruments 2018 - 2030 (USD Million)
  • Fig. 49 Global Immunoassays Market, for, Open-ended Systems 2018 - 2030 (USD Million)
  • Fig. 50 Global Immunoassays Market, for, Closed-ended Systems 2018 - 2030 (USD Million)
  • Fig. 51 Global Immunoassays Market, for, Software & Services 2018 - 2030 (USD Million)
  • Fig. 52 Global Immunoassays Market, for, Radioimmunoassay (RIA) 2018 - 2030 (USD Million)
  • Fig. 53 Global Immunoassays Market, for, Enzyme Immunoassays (EIA) 2018 - 2030 (USD Million)
  • Fig. 54 Global Immunoassays Market, for, Chemiluminescence Immunoassays (CLIA) 2018 - 2030 (USD Million)
  • Fig. 55 Global Immunoassays Market, for, Fluorescence Immunoassays (FIA) 2018 - 2030 (USD Million)
  • Fig. 56 Global Immunoassays Market, for, Rapid Test2018 - 2030 (USD Million)
  • Fig. 57 Global Immunoassays Market, for, Others 2018 - 2030 (USD Million)
  • Fig. 58 Global Immunoassays Market, for, Therapeutic Drug Monitoring2018 - 2030 (USD Million)
  • Fig. 59 Global Immunoassays Market, for, Oncology2018 - 2030 (USD Million)
  • Fig. 60 Global Immunoassays Market, for, Cardiology2018 - 2030 (USD Million)
  • Fig. 61 Global Immunoassays Market, for, Endocrinology2018 - 2030 (USD Million)
  • Fig. 62 Global Immunoassays Market, for, Infectious Disease Testing2018 - 2030 (USD Million)
  • Fig. 63 Global Immunoassays Market, for, Autoimmune Diseases 2018 - 2030 (USD Million)
  • Fig. 64 Global Immunoassays Market, for, Others 2018 - 2030 (USD Million)
  • Fig. 65 Global Immunoassays Market, for, Blood 2018 - 2030 (USD Million)
  • Fig. 66 Global Immunoassays Market, for, Saliva 2018 - 2030 (USD Million)
  • Fig. 67 Global Immunoassays Market, for, Urine 2018 - 2030 (USD Million)
  • Fig. 68 Global Immunoassays Market, for, Other Specimens 2018 - 2030 (USD Million)
  • Fig. 69 Global Immunoassays Market, for, Hospitals 2018 - 2030 (USD Million)
  • Fig. 70 Global Immunoassays Market, for, Blood Banks 2018 - 2030 (USD Million)
  • Fig. 71 Global Immunoassays Market, for, Clinical Laboratories 2018 - 2030 (USD Million)
  • Fig. 72 Global Immunoassays Market, for, Pharmaceutical and Biotech Companies 2018 - 2030 (USD Million)
  • Fig. 73 Global Immunoassays Market, for, Academic Research Centers 2018 - 2030 (USD Million)
  • Fig. 74 Global Immunoassays Market, for, Others 2018 - 2030 (USD Million)